Neutral

Visit FAQs

Latest broker research reports with buy, hold and sell recommendations along with share price targets forecast and upside. Browse thousands of reports and search by company or broker.

Broker Research reports: All reports for Industry - Biotechnology

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	20 Nov 2024	Biocon	Geojit BNP Paribas Target	380.40	376.00	327.05 (16.31%)	Target met	Accumulate	pdf post cache		Broker Report BIOCON LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	12 Feb 2024	Biocon	Axis Direct Target	380.40	285.00	266.70 (42.63%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct The company's capital allocation is on two fronts - R&D and the acquisition of Viatris.This has resulted in returns ratios falling below ~10% despite growth in the business. A huge looming net debt of $1.2 Bn could lead to further stake dilution in Biocon biologics. Recommendation: HOLD pdf Copy Link Share on Share on Share on Share on Alert
	17 Nov 2023	Biocon	Geojit BNP Paribas Target	380.40	260.00	232.75 (63.44%)	Target met	Accumulate	pdf post cache		Broker Report BIOCON LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	13 Nov 2023	Biocon	Axis Direct Target	380.40	250.00	234.80 (62.01%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct We have maintained a Hold on stock. pdf Copy Link Share on Share on Share on Share on Alert
	12 Nov 2023	Biocon	Motilal Oswal Target	380.40	220.00	234.80 (62.01%)		Neutral	pdf post cache		Broker Report Delay in new approvals drags biosimilar prospects Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	16 Aug 2023	Biocon	Geojit BNP Paribas Target	380.40	273.00	257.15 (47.93%)	Target met	Hold	pdf post cache		Broker Report BIOCON LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	14 Aug 2023	Biocon	Axis Direct	380.40	260.00	254.60 (49.41%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct Company Outlook & Guidance: Capital allocation on two fronts - R&D and the acquisition of Viatris - has resulted in returns ratios falling below ~10% despite the growth in the business. A huge looming net debt of $1.4 Bn could lead to further stake dilution in Biocon biologics. pdf Copy Link Share on Share on Share on Share on Alert
	29 May 2023	Biocon	Sharekhan Reco	380.40	266.00	245.20 (55.14%)	Target met	Hold	pdf post cache		Broker Report Biocon Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2023	Biocon	ICICI Securities Limited Reco Target	380.40	250.00	243.00 (56.54%)	Target met	Hold	pdf post cache		Broker Report Tepid organic growth ICICI Securities Limited Biocon Limited’s (Biocon) Q4FY23 performance was boosted by consolidation of the acquired business of biosimilars (segment revenue up 114% YoY) from Viatris. Reported gross margin was inflated by ~150bps and EBITDA margin by 360bps due to licensing income of Rs1.75bn. pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2023	Biocon	Axis Direct	380.40	260.00	239.85 (58.60%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct Current TP: Rs 260/share (Earlier TP: Rs 260/share) pdf Copy Link Share on Share on Share on Share on Alert
	25 May 2023	Biocon	ICICI Direct Target	380.40	235.00	239.85 (58.60%)	Target met	Hold	pdf post cache		Broker Report Biocon ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	24 May 2023	Biocon	Motilal Oswal Target	380.40	260.00	243.00 (56.54%)	Target met	Neutral	pdf post cache		Broker Report 4Q - A miss; efforts underway to build growth levers across segments Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	18 May 2023	Advanced Enzyme	ICICI Direct Target	310.40	310.00	277.95 (11.67%)	Target met	Hold	pdf post cache		Broker Report Advanced Enzyme Technologies ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	09 Mar 2023	Biocon	Geojit BNP Paribas Target	380.40	238.00	223.85 (69.94%)	Target met	Hold	pdf post cache		Broker Report BIOCON LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	20 Feb 2023	Biocon	AUM Capital	380.40	260.00	227.70 (67.06%)	Target met	Neutral	pdf post cache		Broker Report Biocon Ltd AUM Capital pdf Copy Link Share on Share on Share on Share on Alert
	16 Feb 2023	Biocon	Axis Direct Target	380.40	260.00	242.85 (56.64%)	Target met	Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct Recommendation: We maintain HOLD on the stock pdf Copy Link Share on Share on Share on Share on Alert
	16 Feb 2023	Biocon	ICICI Direct Target	380.40	230.00	242.85 (56.64%)	Target met	Hold	pdf post cache		Broker Report Biocon ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	15 Feb 2023	Biocon	Motilal Oswal Target	380.40	250.00	238.10 (59.76%)	Target met	Neutral	pdf post cache		Broker Report Increased opex/financial leverage drags earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	22 Nov 2022	Advanced Enzyme	ICICI Direct Reco Target	310.40	300.00	273.05 (13.68%)	Target met	Hold	pdf post cache		Broker Report Advanced Enzyme Technologies ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	15 Nov 2022	Biocon	Axis Direct Reco Target	380.40	310.00	283.85 (34.01%)		Hold	pdf post cache		Broker Report Result Update:Biocon Axis Direct Management indicated that R&D costs will increase in the upcoming quarters which may pose threat to the current margins of the company. We, therefore, recommend a HOLD rating on the stock with a TP of Rs 310/share. pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners